Truist raises Addus HomeCare price target to $148 and reiterates bullish view
The target increase and explicit bullish language support a positive view, though an analyst target is an opinion rather than a guarantee.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The target increase and explicit bullish language support a positive view, though an analyst target is an opinion rather than a guarantee.
What happened, with direct paths to the underlying reporting
Truist raised its target for ADUS to $148 from an unspecified prior level and said it remains bullish. The posted price of $127.94 implies about 15.7% upside to the target.
Target: $148
Posted price: $127.94
Analyst firm: Truist Financial
Analyst: Clarke Murphy
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.